Analysis of The Boeing Company’s Q3 2026 10-Q
Filing dated 27 October 2026 for the quarter ended 30 September 2026
Where the filing and the story diverge
Boeing is recovering: 737-7 and 737-10 certification is done, Q3 free cash flow was positive at $464M, and management targets about $2B of free cash flow this year rising to $10B by 2029. The 10-Q shows how thin the margin for error is: nine-month operating income of $958M was halved by estimate changes and covered barely half of $1,789M of interest; $31.2B of production costs is deferred against future deliveries, including 777X costs that quadrupled this year; and receivables rose 39% against revenue up 8%.
- Three findings: Operating income of $958M, halved by estimate changes and short of interest costs; $31.2B of production costs deferred, with 777X costs up fourfold; Receivables up 39% against revenue up 8%, with a thinner reserve. Each is set out below with the figure, where it sits in the filing and what would close it.
- On the calls. 1 of 3 findings were sidestepped or never asked.
- What it does not show. Nothing here shows a misstatement.
- Q3 operating income
- $354M
- Nine-month net loss
- $(551)M
- Q3 free cash flow
- $464M
- Net debt
- $25,206M
- 2026 FCF target
- About $2B
Area by area: what is solid and what is stretched
Boeing’s backlog, certifications and cash trend are improving. The risk sits in thin earnings against high interest, large deferred costs tied to production rates and certification, and support for ULA.
Three findings, ranked by importance
Each is set out in full below: what the filing shows, the numbers, the evidence and what would close it.
Operating income of $958M, halved by estimate changes and short of interest costs
Estimate changes cut nine-month earnings by $486M, including $312M on the VC-25B presidential aircraft. Q3 operating income of $354M included a $252M gain on selling HRL Laboratories. Interest expense was $1,789M, so Boeing posted a nine-month pre-tax loss of $462M and a net loss of $551M.
Other income of $369M, mostly a non-service pension credit of about $223M, helped below the operating line. In defense, Q3 margin was 6.2%, and the HRL gain was 51% of that segment’s operating income. Fixed-price development programmes carry further exposure: KC-46A, T-7A and Starliner have $932M of capitalised precontract costs and $1,110M of potential termination liabilities between them. Management said wing-supplier disruption costs will be expensed as abnormal costs over the next few quarters.
10-Q income statement, Note 1 (estimate changes), Note 2 (HRL) and segment note.
$31.2B of production costs deferred, with 777X costs up fourfold
Deferred production costs are $14,036M on the 737 (up 19%), $14,444M on the 787 and $2,731M on the 777X (from $651M at year end), together 34% of $90,948M of inventory. 777X work in progress rose 76% to $7,608M. On the 787, $1,874M is expected to be recovered only from future orders not yet booked.
Deferred production costs are the excess of early, more expensive units over the average programme cost; they are recovered as later units are delivered at higher volumes. That makes them sensitive to production rates: management said Rate 47 on the 737 is taking longer than expected and now targets Rate 52 in the second half of 2027, while its cash targets assume 777X certification by mid-2027. Inventory growth absorbed $6,733M of cash in nine months.
10-Q Note 7 (inventories) and the call for production rates.
Receivables up 39% against revenue up 8%, with a thinner reserve
Receivables rose to $4,069M from $2,921M, and unbilled receivables 11% to $10,179M, against nine-month revenue growth of 8.3%. The allowance for credit losses fell to 2.02% of receivables from 2.60%, and the unbilled allowance halved to $22M.
Operating cash flow of $2,681M over nine months was supported by $8,113M of customer advances and $2,436M of higher payables, while receivables absorbed $1,130M and inventory $6,733M. Free cash flow was $(359)M for nine months but positive $464M in Q3. A thinner reserve on a growing receivables book can be justified by customer quality, but the filing does not say which customers drive the build.
10-Q balance sheet, credit-loss note and cash flow statement.
Other findings, checked and set aside
Each item was tested against the filing. None changes the lead findings above.
| Item | What the filing shows, and why it is not a lead finding |
|---|---|
| XBRL: guarantee dimensions | Boeing tags repurchase commitments ($163M) and financial guarantees ($775M) on separate dimensions; they must not be blended. |
| XBRL: 179 custom elements | 63 used this quarter; all monetary custom values match the printed statements. |
| Quarterly cash flow | The 10-Q cash flow statement is nine-month only; Q3 free cash flow of $464M comes from the results release. |
| Core earnings | Boeing’s own core operating earnings of $204M in Q3 differ from GAAP mainly through the FAS/CAS pension adjustment, as disclosed. |
| Spirit AeroSystems | Purchase accounting is finalised, so no measurement-period adjustments remain. |
| Not found | No supplier-finance programme or related-party transactions disclosed in the 10-Q. |
What management said about each finding
Management flagged future costs: wing-supplier disruption “will be treated as abnormal cost and period expense over the next few quarters.” The estimate-change drag and the HRL gain were not discussed.
Management said “it is taking us longer than we had expected to demonstrate performance at Rate 47”, that “our financial plan will target Rate 52 in the back half of 2027”, and that its cash targets “assume that 777X will be certified by mid-year 2027.”
Receivables and the credit-loss allowance were not mentioned on the call.
7 disclosures moved
10-Q Q3 2026 compared with the 10-K for 31 December 2025.
| Status | Disclosure | Before | Now |
|---|---|---|---|
| New | 737-7 and 737-10 certification Results release; call | Pending | Certified (July and October 2026) |
| New | F/A-XX fighter selection Note 21 | Not present | Selected; not yet in backlog |
| Changed | Financial guarantees Note 12 | $15M | $775M (ULA $750M) |
| Changed | 777X deferred production costs Note 7 | $651M | $2,731M |
| New | HRL Laboratories sale Note 2 | Owned | Sold; $252M gain |
| Removed | DOJ settlement escrow Note 5 | $689M held | Released in Q3 |
| Changed | Receivables Balance sheet | $2,921M | $4,069M |
Certification of two 737 variants, a big defense win not yet in backlog, larger ULA support, the DOJ settlement paid out, and rapid growth in 777X costs.
5 markers
Set before the numbers, so the read can be checked afterwards.
| Marker | Now | Gap widens if | Gap closes if | Result |
|---|---|---|---|---|
| 2026 free cash flow | $(359)M after nine months; target about $2B | Full-year free cash flow falls short of about $2B | About $2B or more | Awaiting |
| Estimate-change charges | $(486)M in nine months | New reach-forward losses or charges in Q4 | None material | Awaiting |
| 777X | Deferred costs $2,731M; certification assumed mid-2027 | Certification slips or deferred costs keep rising sharply | Certification on track and cost growth slows | Awaiting |
| Receivables | +39.3% vs revenue +8.3% | Keep growing faster than revenue | Fall back in line | Awaiting |
| ULA support | $750M guarantee; more support expected in Q4 | Further support provided without the ceiling disclosed | Total support quantified and capped | Awaiting |
These are monitoring checks for the Q4 results in early 2027 (date not yet announced), not forecasts of a loss or breach.
6 questions, checked against the call
What this does and does not show
A guarantee for United Launch Alliance up 52 times
Boeing’s maximum financial-guarantee exposure rose to $775M from $15M, mostly a $750M guarantee for ULA facilities maturing in August 2029; Boeing expects to provide additional financial support in Q4.
Not discussed on the call.
What would resolve this: The total support ceiling is disclosed.
A pension return bigger than the loss
The expected return on pension assets was $2,155M in nine months, 4.7 times the $462M pre-tax loss; the non-service credit lands in other income.
Not discussed on the call.
What would resolve this: The return assumption is disclosed with its sensitivity.
Leverage and the 2027 conversion
Total debt is $45,920M against $20,714M of cash and investments; $4,569M falls due within 12 months; mandatory convertible preferred shares convert in October 2027. Ratings sit at the lowest investment-grade notch.
Not discussed on the call.
What would resolve this: Free cash flow targets are met and debt falls.
Nothing here shows a misstatement.
Estimate changes, deferred costs and guarantees are disclosed in the notes, and cash flow turned positive in Q3.
- Full-year free cash flow reaches about $2B
- No new charges
- 777X stays on track
- ULA support is capped
- Free cash flow misses the target
- New reach-forward losses
- 777X certification slips
- Further guarantee increases
Every figure ties back to the filing
| Boeing Form 10-Q, quarter ended 30 September 2026 | Open ↗ |
| Q3 2026 results release (Exhibit 99.1), 27 October 2026 | Filed with the SEC |
| Q3 2026 earnings call, 27 October 2026 | Third-party transcripts |
Helmledgers reads the full filing, including the notes, and ties every figure to the statement or note it comes from, with each number re-checked against the source before release. This is an accounting read of public SEC filings, not an audit opinion and not investment advice.
- Severity
- High: material effect on cash, debt or reported results. Medium: worth tracking, smaller or less certain effect.
- On the call
- Direct answer, Partly answered (topic addressed, figure missing), Sidestepped (raised but not answered) or Not asked.
- Since the read
- Confirmed by a later disclosure, Escalated (grown since), Open (untested) or Missed (not flagged by the read).
- Said versus done
- Kept, Slipped (late), Changed (plan or terms changed), Missed or Reversed.
- Markers
- Measurable checks set before results, each with what would widen or close the gap. Scored after the next results.
- Closes if
- The evidence that would resolve a finding.
Helmledgers and its analysts hold no position in Boeing (BA) securities.
This is an accounting read of public SEC filings. It is not an audit opinion and not investment advice.